To our knowledge, F8-IL10 will be the first anti-inflammatory immunocytokine to be tested in the clinical setting and it will be interesting to learn whether the improved performance and selectivity documented in the mouse model of arthritis holds true for patients with rheumatoid disease. The gene discussed is IL10; the disease is arthritic joint disease.